STACS — 2015025
Application number
2015025
Registration number
TMA1307716
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2020-03-02
Registered
2025-04-23
Registration Expiry Date
2035-04-23
Registered Owner
STACS DNA INC.
Unit 206, 2255 St. Laurent Boulevard
Ottawa
ONTARIO K1G4K3
Agent
PERLEY-ROBERTSON, HILL & MCDOUGALL LLP
1400 - 340 ALBERT STREET
OTTAWA
ONTARIO K1R0A5
Documents
Index headings
- STACS
- STACKS
Goods (Nice class & Statement)
- 9
- (1) Computer software, namely, sample management software for managing the intake, testing, storage and analysis of DNA samples for forensic testing; Computer software, namely, software for managing the intake, testing, storage and analysis of chemical preparations for use in the manufacture of pharmaceuticals for determining whether said pharmaceuticals are counterfeit products; Computer software, namely, software for managing the intake, tracking, prioritization, and processing of evidence for forensic purposes, namely, blood samples, urine samples, DNA samples, ballistics samples, and fingerprint samples.
Services (Nice class & Statement)
- 41
- (1) Training in the use and operation of computer software, namely, sample management software for managing the intake, testing, storage and analysis of DNA samples for forensic testing; Training in the use and operation of computer software, namely, sample management software for managing the intake, testing, storage and analysis of chemical preparations for use in the manufacture of pharmaceuticals for determining whether said pharmaceuticals are counterfeit products; Training in the use and operation of computer software, namely, software for managing the intake, tracking, prioritization, and processing of evidence for forensic purposes, namely, blood samples, urine samples, DNA samples, ballistics samples, and fingerprint samples.
- 42
- (2) Software as a service (SaaS) provider featuring sample management software for managing the intake, testing, storage and analysis of DNA samples for forensic testing; Software as a service (SaaS) provider featuring sample management software for managing the intake, testing, storage and analysis of chemical preparations for use in the manufacture of pharmaceuticals for determining whether said pharmaceuticals are counterfeit products; Software as a service (SaaS) provider featuring software for managing the intake, tracking, prioritization, and processing of evidence for forensic purposes, namely, blood samples, urine samples, DNA samples, ballistics samples, and fingerprint samples; SaaS services featuring sample management software for managing the intake, testing, storage and analysis of DNA samples for forensic testing; SaaS services featuring sample management software for managing the intake, testing, storage and analysis of chemical preparations for use in the manufacture of pharmaceuticals for determining whether said pharmaceuticals are counterfeit products; SaaS services featuring software for managing the intake, tracking, prioritization, and processing of evidence for forensic purposes, namely, blood samples, urine samples, DNA samples, ballistics samples, and fingerprint samples; consultancy services in the field of sample management, namely, managing the intake, testing, storage and analysis of DNA samples for forensic testing; consultancy services in the field of sample management, namely, managing the intake, testing, storage and analysis of chemical preparations for use in the manufacture of pharmaceuticals for determining whether said pharmaceuticals are counterfeit products; consultancy services in the field of sample management, namely, managing the intake, tracking, prioritization, and processing of evidence for forensic purposes, namely, blood samples, urine samples, DNA samples, ballistics samples, and fingerprint samples; developing customized software relating to sample management, namely, managing the intake, testing, storage and analysis of DNA samples for forensic testing; developing customized software relating to sample management, namely, managing the intake, testing, storage and analysis of chemical preparations for use in the manufacture of pharmaceuticals for determining whether said pharmaceuticals are counterfeit products; developing customized software for managing the intake, tracking, prioritization, and processing of evidence for forensic purposes, namely, blood samples, urine samples, DNA samples, ballistics samples, and fingerprint samples.
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2020-03-02 | ||
| Created | 2020-03-02 | ||
| Formalized | 2020-03-02 | ||
| Pre-Assessment Letter Sent | 2022-06-08 | Goods or Services Not Acceptable | |
| Search Recorded | 2024-06-14 | ||
| Examiner's First Report | 2024-06-14 | 2024-12-14 | |
| Approved | 2025-01-10 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-01-10 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-02-05 | Vol.72 Issue 3667 | |
| Registration Pending | 2025-04-23 | ||
| Registered | 2025-04-23 | 2035-04-23 |